Position in AVXL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,749,764
+$114,323 QoQ
Shares Held
569,956
+24.1% QoQ
Ownership
0.615%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$186,200
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. AVXL ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in AVXL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,749,764 | 569,956 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,635,441 | 459,394 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,378,593 | 491,977 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,371,698 | 474,154 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,216,810 | 608,020 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,497,524 | 418,764 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $738,723 | 130,057 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $601,936 | 142,639 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,114,807 | 415,483 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,911,202 | 205,285 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $186,200 | 20,000 | Put | Defined | 2024-02-09 | |
| 2023-09-30 | $664,044 | 101,381 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,079,452 | 132,774 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,562,738 | 182,350 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,913,853 | 314,671 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $494,894 | 47,955 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $807,155 | 80,635 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,339,471 | 352,516 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,815,527 | 220,042 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,213,282 | 179,013 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $146,738 | 6,419 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $995,729 | 66,604 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $80,519 | 14,911 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,375 | 2,500 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $103,580 | 21,053 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $103,751 | 32,937 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||